TrialPanorama/TrialPanorama-database huggingface dataset:
Study NCT03431532 — Predictive Biomarker (PRD): CD14 mRNA
Genes: CD14
Study NCT03431532 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT01350310 — Predictive Biomarker (PRD): CD34 mRNA
Genes: CD34
Study NCT01334060 — Predictive Biomarker (PRD): WT1 mRNA
Genes: WT1
Study NCT02676414 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03998540 — Predictive Biomarker (PRD): TTN mRNA
Genes: TTN
Study NCT01315353 — Surrogate Endpoint (SUR): Cervical intraepithelial neoplasia
Study NCT03531944 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03430479 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT05186870 — Predictive Biomarker (PRD): NF1 mRNA
Genes: NF1
Study NCT01108107 — Predictive Biomarker (PRD): KRAS mRNA
Genes: KRAS; KRAS2; RASK2
Study NCT01108107 — Predictive Biomarker (PRD): PIK3CA mRNA
Genes: PIK3CA
Study NCT03939780 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY): Microtubule-associated protein tau
Genes: MAPT; MAPTL; MTBT1; TAU
Study NCT03362567 — Predictive Biomarker (PRD): Mitochondrial n-acetylglutamate synthase
Genes: NAGS
Study NCT04858958 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT04816331 — Predictive Biomarker (PRD): NLRP3 mRNA
Genes: NLRP3; C1orf7; CIAS1; NALP3; PYPAF1
Study NCT04816331 — Predictive Biomarker (PRD): PYCARD mRNA
Genes: PYCARD; ASC; CARD5; TMS1
Study NCT01188772 — Predictive Biomarker (PRD): IFNL3 mRNA
Genes: IFNL3; IL28B; IL28C; ZCYTO22
Study NCT02304770 — Surrogate Endpoint (SUR): Cervical intraepithelial neoplasia
Study NCT00894153 — Predictive Biomarker (PRD); Safety Biomarker (SAF): TP53
Genes: p53; LFS1
Study NCT02196961 — Predictive Biomarker (PRD): MCC mRNA
Genes: MCC
Study NCT00530907 — Pharmacodynamic Biomarker (PDY): Valproic acid
Study NCT02247596 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00313482 — Predictive Biomarker (PRD): NPEPPS mRNA
Genes: NPEPPS; PSA
Study NCT01849159 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT01849159 — Predictive Biomarker (PRD): MSC mRNA
Genes: MSC; ABF1; BHLHA22
Study NCT01849159 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT03938545 — Predictive Biomarker (PRD): TSHR mRNA
Genes: TSHR; LGR3
Study NCT04268186 — Predictive Biomarker (PRD): MCC mRNA
Genes: MCC
Study NCT01580696 — Predictive Biomarker (PRD): FBP1 mRNA
Genes: FBP1; FBP
Study NCT01580696 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT01580696 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT00183001 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT00589134 — Predictive Biomarker (PRD): Arginine vasopressin
Genes: AVP; ARVP; VP
Study NCT00589134 — Surrogate Endpoint (SUR): Serum sodium
Study NCT03237637 — Predictive Biomarker (PRD): Hypoxia-inducible factor 1-alpha
Genes: HIF1A; BHLHE78; MOP1; PASD8
Study NCT03455842 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY): Interleukin 6 receptor alpha
Genes: IL6R
Study NCT03268772 — Predictive Biomarker (PRD): STS mRNA
Genes: STS; ARSC1
Study NCT02341482 — Predictive Biomarker (PRD): CYP3A4 mRNA
Genes: CYP3A4; CYP3A3
Study NCT00886496 — Predictive Biomarker (PRD): MBL2 mRNA
Genes: MBL2; COLEC1; MBL
Study NCT03970460 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT01090531 — Monitoring Biomarker (MOI): HBV DNA
Study NCT04681612 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00117975 — Predictive Biomarker (PRD): CD80 mRNA
Genes: CD80; CD28LG; CD28LG1; LAB7
Study NCT03410693 — Predictive Biomarker (PRD): FGFR1 mRNA
Genes: FGFR1; BFGFR; CEK; FGFBR; FLG; FLT2; HBGFR
Study NCT02083159 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT02072161 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT00545051 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT01344993 — Predictive Biomarker (PRD): RPE mRNA
Genes: RPE; HUSSY-17
Study NCT03690232 — Safety Biomarker (SAF): Hyaluronic acid
Study NCT03720873 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT00003849 — Predictive Biomarker (PRD): Leukocyte surface antigen Leu-16
Genes: MS4A1; CD20
Study NCT01844765 — Predictive Biomarker (PRD): BCR mRNA
Genes: BCR; BCR1; D22S11
Study NCT01844765 — Pharmacodynamic Biomarker (PDY): Tyrosine-protein kinase ABL1
Genes: ABL1; ABL; JTK7
Study NCT04038502 — Predictive Biomarker (PRD): BARD1 mRNA
Genes: BARD1
Study NCT04038502 — Predictive Biomarker (PRD): BRCA1 mRNA
Genes: BRCA1; RNF53
Study NCT04038502 — Predictive Biomarker (PRD): BRCA2 mRNA
Genes: BRCA2; FACD; FANCD1
Study NCT04038502 — Predictive Biomarker (PRD): CHEK1 mRNA
Genes: CHEK1; CHK1
Study NCT04038502 — Predictive Biomarker (PRD): FANCL mRNA
Genes: FANCL; PHF9
Study NCT04038502 — Predictive Biomarker (PRD): PALB2 mRNA
Genes: PALB2; FANCN
Study NCT04038502 — Predictive Biomarker (PRD): RAD51B mRNA
Genes: RAD51B; RAD51L1; REC2
Study NCT04038502 — Predictive Biomarker (PRD): RAD51C mRNA
Genes: RAD51C; RAD51L2
Study NCT04038502 — Predictive Biomarker (PRD): Homologous recombination deficiency
Study NCT02429635 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02057523 — Predictive Biomarker (PRD): POMC
Genes: MSH; POC; CLIP; ACTH; NPP; LPH
Study NCT04342793 — Predictive Biomarker (PRD): IGFALS mRNA
Genes: IGFALS; ALS
Study NCT02835833 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT02835833 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study NCT00211185 — Predictive Biomarker (PRD): DDIT3 mRNA
Genes: DDIT3; CHOP; CHOP10; GADD153
Study NCT04322591 — Predictive Biomarker (PRD): RET mRNA
Genes: RET; CDHF12; CDHR16; PTC; RET51
Study NCT01243762 — Predictive Biomarker (PRD): KRAS mRNA
Genes: KRAS; KRAS2; RASK2
Study NCT03934034 — Predictive Biomarker (PRD): NTM mRNA
Genes: NTM; IGLON2; NT; UNQ297/PRO337
Study NCT02479321 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03612869 — Predictive Biomarker (PRD): SGSH mRNA
Genes: SGSH; HSS
Study NCT00413322 — Predictive Biomarker (PRD): Thymidylate synthase 
Genes: TYMS; TS; OK/SW-cl.29
Study NCT01521975 — Monitoring Biomarker (MOI): HBV DNA
Study NCT02967055 — Predictive Biomarker (PRD): ENG mRNA
Genes: ENG; END
Study NCT00980187 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study NCT00980187 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01413035 — Predictive Biomarker (PRD): MSC mRNA
Genes: MSC; ABF1; BHLHA22
Study NCT03253679 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY): CCNE1 mRNA
Genes: CCNE1; CCNE
Study NCT04894487 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04822831 — Predictive Biomarker (PRD): MIP mRNA
Genes: MIP; AQP0
Study NCT04439682 — Predictive Biomarker (PRD); Monitoring Biomarker (MOI): BDNF mRNA
Genes: BDNF
Study NCT04439682 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT04439682 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT04866498 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01207297 — Surrogate Endpoint (SUR): Serum creatinine
Study NCT00159276 — Predictive Biomarker (PRD): TSC22D3 mRNA
Genes: TSC22D3; DSIPI; GILZ
Study NCT00159276 — Predictive Biomarker (PRD): SLPI mRNA
Genes: SLPI; WAP4; WFDC4
Study NCT03418831 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study NCT01657513 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT03819985 — Predictive Biomarker (PRD): STS mRNA
Genes: STS; ARSC1
Study NCT02433626 — Predictive Biomarker (PRD); Safety Biomarker (SAF): TP53
Genes: p53; LFS1
Study NCT02914158 — Predictive Biomarker (PRD): Hormone receptor
Study NCT00841880 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04412044 — Predictive Biomarker (PRD): Interleukin 5
Genes: IL5
Study NCT04563871 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT03566654 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01545323 — Predictive Biomarker (PRD): SPINK5 mRNA
Genes: SPINK5
Study NCT00008073 — Predictive Biomarker (PRD): SMS mRNA
Genes: SMS
Study NCT00953576 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT00250939 — Safety Biomarker (SAF): Lysosomal alpha-glucosidase
Genes: GAA
Study NCT03639467 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor receptor 2
Genes: KDR; FLK1; VEGFR2
Study NCT03639467 — Predictive Biomarker (PRD): FLT4 mRNA
Genes: FLT4; VEGFR3
Study NCT02753166 — Predictive Biomarker (PRD); Monitoring Biomarker (MOI): FKBP5 mRNA
Genes: FKBP5; AIG6; FKBP51
Study NCT03773159 — Safety Biomarker (SAF): von Willebrand factor
Genes: VWF; F8VWF
Study NCT00568438 — Predictive Biomarker (PRD): SLC5A5 mRNA
Genes: SLC5A5; NIS
Study NCT02568176 — Predictive Biomarker (PRD): CYP2B6 mRNA
Genes: CYP2B6
Study NCT00145795 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT02574403 — Pharmacodynamic Biomarker (PDY): Complement C5
Genes: C5; CPAMD4
Study NCT02216669 — Predictive Biomarker (PRD): Carbonic anhydrase IX
Genes: CA9; G250; MN
Study NCT02536807 — Safety Biomarker (SAF): Hyaluronic acid
Study NCT02277002 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01242137 — Predictive Biomarker (PRD): CYP2C9 mRNA
Genes: CYP2C9; CYP2C10
Study NCT04277949 — Predictive Biomarker (PRD); Safety Biomarker (SAF): TP53
Genes: p53; LFS1
Study NCT05636605 — Safety Biomarker (SAF): PDCD1
Genes: CD279; PD1; hSLE1; PD-1
Study NCT02134223 — Predictive Biomarker (PRD); Monitoring Biomarker (MOI): BDNF mRNA
Genes: BDNF
Study NCT03250728 — Predictive Biomarker (PRD): PROCR mRNA
Genes: PROCR; EPCR
Study NCT02155816 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT00407277 — Predictive Biomarker (PRD): CHRNA7 mRNA
Genes: CHRNA7; NACHRA7
Study NCT01164995 — Predictive Biomarker (PRD); Safety Biomarker (SAF): TP53
Genes: p53; LFS1
Study NCT01164995 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Cellular tumor antigen p53
Genes: TP53; P53
Study NCT04112121 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study NCT04401267 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03799237 — Predictive Biomarker (PRD): IVNS1ABP mRNA
Genes: IVNS1ABP; ARA3; FLARA3; KIAA0850; KLHL39; NS1; NS1BP; HSPC068
Study NCT03461393 — Predictive Biomarker (PRD): AMD1 mRNA
Genes: AMD1; AMD
Study NCT04056650 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00843232 — Pharmacodynamic Biomarker (PDY): Gastric inhibitory polypeptide
Genes: GIP
Study NCT00843232 — Pharmacodynamic Biomarker (PDY): Dipeptidyl peptidase 4
Genes: DPP4; ADCP2; CD26
Study NCT02357017 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01090622 — Predictive Biomarker (PRD): DNA repair endonuclease XPF
Genes: ERCC4; ERCC11; XPF
Study NCT02949466 — Safety Biomarker (SAF): Hyaluronic acid
Study NCT01292954 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02518126 — Predictive Biomarker (PRD): LIF mRNA
Genes: LIF; HILDA
Study NCT04179929 — Predictive Biomarker (PRD): BCR mRNA
Genes: BCR; BCR1; D22S11
Study NCT04179929 — Pharmacodynamic Biomarker (PDY): Tyrosine-protein kinase ABL1
Genes: ABL1; ABL; JTK7
Study NCT03349203 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT04161495 — Safety Biomarker (SAF): von Willebrand factor
Genes: VWF; F8VWF
Study NCT04161495 — Predictive Biomarker (PRD): Coagulation factor VIII
Genes: F8; F8C
Study NCT02319577 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT02319577 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT02362529 — Predictive Biomarker (PRD): TSPO mRNA
Genes: TSPO; BZRP; MBR
Study NCT04433546 — Predictive Biomarker (PRD): VIP mRNA
Genes: VIP
Study NCT02662075 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT02662075 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT02662075 — Safety Biomarker (SAF): von Willebrand factor
Genes: VWF; F8VWF
Study NCT03602170 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00125502 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT01757808 — Predictive Biomarker (PRD): PAH mRNA
Genes: PAH
Study NCT01757808 — Surrogate Endpoint (SUR): Pulmonary vascular resistance
Study NCT02735720 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02226276 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT02226276 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT03562247 — Surrogate Endpoint (SUR): Forced vital capacity
Study NCT03858101 — Predictive Biomarker (PRD): PAH mRNA
Genes: PAH
Study NCT02242864 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00078078 — Safety Biomarker (SAF): MTR
Genes: cblG
Study NCT00078078 — Predictive Biomarker (PRD): ACSF3 mRNA
Genes: ACSF3; PSEC0197
Study NCT00078078 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Monitoring Biomarker (MOI): Vitamin B12
Study NCT02627326 — Surrogate Endpoint (SUR): Probing pocket depth
Study NCT00683124 — Predictive Biomarker (PRD): FBN1 mRNA
Genes: FBN1; FBN
Study NCT03901170 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study NCT04366297 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT04245982 — Predictive Biomarker (PRD): PPARA mRNA
Genes: PPARA; NR1C1; PPAR
Study NCT04245982 — Predictive Biomarker (PRD): VDR mRNA
Genes: VDR; NR1I1
Study NCT05814380 — Predictive Biomarker (PRD): TTR mRNA
Genes: TTR; PALB
Study NCT02814929 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study NCT00413972 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT00045513 — Predictive Biomarker (PRD): UCN mRNA
Genes: UCN
Study NCT03523104 — Pharmacodynamic Biomarker (PDY): Leucine-rich repeat kinase 2
Genes: LRRK2; PARK8
Study NCT04320394 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Interferon gamma
Genes: IFNG
Study NCT01914146 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00348855 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04028869 — Predictive Biomarker (PRD): AFP mRNA
Genes: AFP; HPAFP
Study NCT01002612 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT04123886 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT03367767 — Predictive Biomarker (PRD): AMD1 mRNA
Genes: AMD1; AMD
Study NCT00585195 — Predictive Biomarker (PRD): Proto-oncogene c-Met
Genes: MET
Study NCT00585195 — Predictive Biomarker (PRD): MET
Genes: HGFR; RCCP2; DFNB97
Study NCT00585195 — Predictive Biomarker (PRD): ALK tyrosine kinase receptor
Genes: ALK
Study NCT00585195 — Predictive Biomarker (PRD): ROS1
Genes: MCF3; ROS; c-ros-1
Study NCT00585195 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Hepatocyte growth factor
Genes: HGF; HPTA
Study NCT00668421 — Predictive Biomarker (PRD): JAK2 mRNA
Genes: JAK2
Study NCT04386187 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT02693171 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT00828243 — Predictive Biomarker (PRD): SFTPB mRNA
Genes: SFTPB; SFTP3
Study NCT00828243 — Predictive Biomarker (PRD): SFTPC mRNA
Genes: SFTPC; SFTP2
Study NCT00828243 — Predictive Biomarker (PRD): ABCA3 mRNA
Genes: ABCA3; ABC3
Study NCT02137863 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00121563 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT02115594 — Predictive Biomarker (PRD): Hormone receptor
Study NCT01081093 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02035865 — Predictive Biomarker (PRD); Safety Biomarker (SAF): CAV1 mRNA
Genes: CAV1; CAV
Study NCT02677480 — Pharmacodynamic Biomarker (PDY): Salivary secretion
Study NCT01548079 — Pharmacodynamic Biomarker (PDY): Fibroblast growth factor 19
Genes: FGF19; UNQ334/PRO533
Study NCT03542370 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03532087 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT03532087 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT03532087 — Predictive Biomarker (PRD): TNFRSF11B mRNA
Genes: TNFRSF11B; OCIF; OPG
Study NCT03532087 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT01472666 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00690573 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT01011998 — Pharmacodynamic Biomarker (PDY): Valproic acid
Study NCT01889823 — Predictive Biomarker (PRD): Hypoxia-inducible factor 1-alpha
Genes: HIF1A; BHLHE78; MOP1; PASD8
Study NCT03092583 — Predictive Biomarker (PRD): DNMT1 mRNA
Genes: DNMT1; AIM; CXXC9; DNMT
Study NCT03092583 — Predictive Biomarker (PRD): MBD2 mRNA
Genes: MBD2
Study NCT02583165 — Predictive Biomarker (PRD): TNFRSF18 mRNA
Genes: TNFRSF18; AITR; GITR; UNQ319/PRO364
Study NCT00381134 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01466608 — Safety Biomarker (SAF): SLCO1B1
Genes: OATP-C; LST-1; OATP1B1
Study NCT00314262 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT00314262 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT01429194 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study NCT00206700 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT03573466 — Pharmacodynamic Biomarker (PDY): Superoxide dismutase Cu-Zn
Genes: SOD1
Study NCT00544570 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT00745810 — Safety Biomarker (SAF): Reactive oxygen species
Study NCT02054988 — Predictive Biomarker (PRD): CYP1A2 mRNA
Genes: CYP1A2
Study NCT03426995 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT03426995 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT04390022 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT02619149 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT03525288 — Predictive Biomarker (PRD): Glutamate carboxypeptidase II
Genes: FOLH1; FOLH; NAALAD1; PSM; PSMA; GIG27
Study NCT03429244 — Predictive Biomarker (PRD): Glutamate carboxypeptidase II
Genes: FOLH1; FOLH; NAALAD1; PSM; PSMA; GIG27
Study NCT01758770 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT01068535 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00975000 — Surrogate Endpoint (SUR): Serum calcium
Study NCT00975000 — Predictive Biomarker (PRD): Intact parathyroid hormone
Study NCT00703222 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study NCT01388036 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01717300 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT01717300 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study NCT05025202 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03504501 — Safety Biomarker (SAF): RAS pathway
Study NCT00686725 — Predictive Biomarker (PRD): O-6-methylguanine-DNA-alkyltransferase
Genes: MGMT
Study NCT03237351 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00898898 — Predictive Biomarker (PRD): MYC mRNA
Genes: MYC; BHLHE39
Study NCT00898898 — Predictive Biomarker (PRD): TOP2A mRNA
Genes: TOP2A; TOP2
Study NCT00898898 — Predictive Biomarker (PRD): Phosphatase and tensin homolog
Genes: PTEN; MMAC1; TEP1
Study NCT01290458 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study NCT01290458 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT02486484 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT04158050 — Predictive Biomarker (PRD): Interleukin 5
Genes: IL5
Study NCT00759369 — Predictive Biomarker (PRD): PRKD1 mRNA
Genes: PRKD1; PKD; PKD1; PRKCM
Study NCT00759369 — Predictive Biomarker (PRD): PKD2 mRNA
Genes: PKD2; TRPP2
Study NCT05577819 — Predictive Biomarker (PRD): TTR mRNA
Genes: TTR; PALB
Study NCT01827137 — Predictive Biomarker (PRD): WT1 mRNA
Genes: WT1
Study NCT04592445 — Predictive Biomarker (PRD): GSN mRNA
Genes: GSN
Study NCT04408625 — Predictive Biomarker (PRD): GRN mRNA
Genes: GRN
Study NCT02430064 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT02430064 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study NCT01952496 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT00781287 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT02855203 — Safety Biomarker (SAF): PDCD1
Genes: CD279; PD1; hSLE1; PD-1
Study NCT00338884 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study NCT02046993 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04133233 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study NCT00430794 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03753659 — Safety Biomarker (SAF): PDCD1
Genes: CD279; PD1; hSLE1; PD-1
Study NCT00171600 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05402930 — Surrogate Endpoint (SUR): Pathological complete response
Study NCT04668469 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): D-dimer
Study NCT00801541 — Predictive Biomarker (PRD): AMD1 mRNA
Genes: AMD1; AMD
Study NCT02541123 — Predictive Biomarker (PRD): GFAP mRNA
Genes: GFAP
Study NCT03552874 — Predictive Biomarker (PRD): DMD mRNA
Genes: DMD
Study NCT01910545 — Predictive Biomarker (PRD): MELK mRNA
Genes: MELK; KIAA0175
Study NCT01144572 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study NCT01045460 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT03426774 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03716609 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01210664 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT04321369 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS